¡Ya estamos en !
Descubre más
Nutriband Inc Warrant
NTRBW
NTRBW
Excluida de cotización
NTRBW dejó de cotizar en bolsa el 30 de septiembre de 2026.
Acerca de: Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Empleados: 3
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
100%
Negativo
0%
Gráficos de precios implementados con Lightweight Charts™